Resectable Pancreatic Head Cancer clinical trials

Explore recruiting resectable pancreatic head cancer clinical trials.

Recruiting resectable pancreatic head cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Resectable Pancreatic Head Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer : a multicentre, randomised, phase 2 trial (Nordic Pancreatic Cancer Trial (NORPACT) – 1

Sweden, Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Resectable Pancreatic Head Cancer trials by city

Resectable Pancreatic Head Cancer in Toronto Resectable Pancreatic Head Cancer in Vancouver Resectable Pancreatic Head Cancer in Montreal Resectable Pancreatic Head Cancer in Calgary Resectable Pancreatic Head Cancer in Edmonton Resectable Pancreatic Head Cancer in Ottawa Resectable Pancreatic Head Cancer in Winnipeg Resectable Pancreatic Head Cancer in Quebec City Resectable Pancreatic Head Cancer in Hamilton Resectable Pancreatic Head Cancer in Kitchener Resectable Pancreatic Head Cancer in London Resectable Pancreatic Head Cancer in Halifax Resectable Pancreatic Head Cancer in New York Resectable Pancreatic Head Cancer in Los Angeles Resectable Pancreatic Head Cancer in Chicago Resectable Pancreatic Head Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease